HomeBOLT • NASDAQ
Bolt Biotherapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 3.95M | -28.66% |
Net income | -15.94M | 10.99% |
Net profit margin | — | — |
Earnings per share | -0.42 | 10.64% |
EBITDA | -15.24M | 21.02% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.32M | -53.69% |
Total assets | 99.63M | -37.65% |
Total liabilities | 42.43M | -9.80% |
Total equity | 57.20M | — |
Shares outstanding | 38.34M | — |
Price to book | 0.22 | — |
Return on assets | -37.49% | — |
Return on capital | -45.39% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.94M | 10.99% |
Cash from operations | -14.43M | -1.16% |
Cash from investing | 12.23M | -22.63% |
Cash from financing | 29.00K | -72.64% |
Net change in cash | -2.17M | -231.45% |
Free cash flow | -9.98M | -66.39% |
Previous close
$0.32
Day range
$0.31 - $0.35
Year range
$0.30 - $1.34
Market cap
12.45M USD
Avg Volume
136.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
52
